<DOC>
	<DOCNO>NCT00755482</DOCNO>
	<brief_summary>The objective trial evaluate effect Aquamin F versus placebo NSAID ( non-steroidal anti-inflammatory drug ) dose reduction subject osteoarthritis knee . Hypothesis 1 : After 12 week treatment , subject take Aquamin F use significantly less NSAID medication symptom osteoarthritis versus placebo alone . Hypothesis 2 : No significant difference see adverse event subject take Aquamin F placebo .</brief_summary>
	<brief_title>Effects Aquamin F NSAID Dose Reduction Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>Subjects age 35 75 , male female Subjects diagnose symptomatic moderate severe osteoarthritis knee accord modify criteria American College Rheumatology 17,18 Subjects present osteoarthritis knee judge symptom disability detectable publish , validated questionnaire previous diagnosis physician subject symptomatic daily near daily pain stiffness osteoarthritis subject take nonsteroidal antiinflammatory drug ( NSAIDs ) prior study enrollment subject willing stop NSAIDS use acetaminophen pain management trial subject screen WOMAC osteoarthritis index total score ( transform score ) 75 subject ability comprehend complete questionnaire form subject whose schedule permit clinical evaluation every four week subject willing stop take calcium supplement , restrict consumption high calcium food 600mg ( two dairy serving ) per day subject high probability compliance study procedure test article consumption subject willing able follow protocol guideline schedule complete diary subject likely abstain take unathorized supplement participate clinical trial experimental treatment trial subject normal gastrointestinal digestion absorption subject history inflammatory arthritis , gout , pseudogout , Paget 's disease , seizure disorder , insulin dependent diabetes mellitus , uncontrolled hypertension , unstable cardiovascular disease , active hepatic renal disease , active cancer and/or HIV infection subject nonambulatory bedridden due osteoarthritis subject dependent prescription drug control pain subject clinical trial experimental treatment past 3 month subject pregnant , lactate risk become pregnant subject receive : intramuscular corticosteroid injection systemic corticosteroid administration within 4 week prior study enrollment , intraarticular corticosteroid injection within 2 month prior study enrollment intraarticular hyaluronic acid injection within 4 month prior study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Aquamin F</keyword>
	<keyword>NSAID</keyword>
</DOC>